NCM·Healthcare·$127M·#21 / 520 in Healthcare
OPRX OptimizeRx Corporation
77SOLID
CATEGORY BREAKDOWN
GROWTH30
QUALITY83
STABILITY95
VALUATION99
GOVERNANCE79
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+18.8%
30
> 50% strong
Gross Margin
Revenue retained after direct costs
67.3%
96
> 50% strong
Cash Runway
Months of cash at current burn rate
999 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
20.3%
84
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.2x
99
< 3x strong
Rule of 40
Growth rate plus operating margin
30
65
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
11.8%
69
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-7.3%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE OPRX WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when OPRX's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.